DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done
In Brief: Hellman Succeeds Perez As ASTR President Hanks Named President Elect; Kligerman Gold Medalist
DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards
Program Announcements For Studies On Blue Collar Workers, Children Released By DRCCA
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival









